LONDRES e BANGKOK, Tailândia, July 03, 2023 (GLOBE NEWSWIRE) — A Aztiq Pharma Partners ("Aztiq"), uma empresa de private equity focada no setor de cincias da vida, e a Innobic (Asia) Company Limited ("Innobic"), o brao de [...] Read more »
Aztiq und Innobic geben den Preis für Sekundärverkauf von Lotus-Stammaktien durch AEMH bekannt
LONDON und BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) — Aztiq Pharma Partners ("Aztiq"), eine auf den Biowissenschaftssektor spezialisierte Private–Equity–Gesellschaft, und Innobic (Asia) Company Limited [...] Read more »
Aztiq et Innobic annoncent le prix de vente secondaire des actions ordinaires de Lotus par l'AEMH
LONDRES et BANGKOK, Thaïlande, 03 juill. 2023 (GLOBE NEWSWIRE) — Aztiq Pharma Partners ( Aztiq ), une socit de capital–investissement axe sur le secteur des sciences de la vie, et Innobic (Asia) Company Limited ( [...] Read more »
Tuberculosis: A Disease of the Poor Begs For Rich Funding
Read more »
How the Security Council can Better Pursue Accountability for International Crimes Against Children
Women in Peru’s Poor Urban Areas Combat the Crisis at the Cost of Their Wellbeing
Read more »
Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH
LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) — Aztiq Pharma Partners ("Aztiq"), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited [...] Read more »